The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Nintendo Shares Tumble as Weak Forecast and Rising Switch 2 Costs Worry Investors
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
US Auto Industry Urges Trump to Block Chinese EV Market Access
Trump DOJ Challenges Colorado’s Large-Capacity Magazine Ban in Second Amendment Lawsuit
US Trade Court Blocks Trump’s 10% Global Tariffs
Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
US Inflation Expected to Rise Again in April as Fed Signals Higher Interest Rates
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Sinaloa Governor Ruben Rocha Denies U.S. Cartel Allegations, Calls Charges Political
Reliance Industries Reworks Jio IPO Into Fresh Share Sale Amid Valuation Talks
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



